The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis.

Tsianakas A, Brunner PM, Ghoreschi K, Berger C, Loser K, Röcken M, Stingl G, Luger T, Jung T.

Open source

DOI
10.1111/exd.12927
Published
2016-02-13
Container
Exp Dermatol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/exd.12927,
  title = {The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis.},
  author = {Tsianakas A and  Brunner PM and  Ghoreschi K and  Berger C and  Loser K and  Röcken M and  Stingl G and  Luger T and  Jung T.},
  year = {2016},
  journal = {Exp Dermatol},
  doi = {10.1111/exd.12927},
  url = {https://doi.org/10.1111/exd.12927}
}

RIS

TY  - JOUR
TI  - The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis.
AU  - Tsianakas A
AU  -  Brunner PM
AU  -  Ghoreschi K
AU  -  Berger C
AU  -  Loser K
AU  -  Röcken M
AU  -  Stingl G
AU  -  Luger T
AU  -  Jung T.
PY  - 2016
JO  - Exp Dermatol
DO  - 10.1111/exd.12927
UR  - https://doi.org/10.1111/exd.12927
ER  - 

APA

A, T., PM, B., K, G., C, B., K, L., M, R., G, S., T, L., & T., J. (2016). The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis.. Exp Dermatol. https://doi.org/10.1111/exd.12927

Source records